Amneal Pharmaceuticals, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Directors: Chintu Patel

Amneal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Chintu Patel”): 270,365,045 for, 1,320,024 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2027 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 64,365,631 for, 158,822 against, 20,002 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Election of Directors: Chirag Patel

Amneal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Chirag Patel”): 270,364,571 for, 1,320,525 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2027 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 64,365,631 for, 158,822 against, 20,002 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Election of Directors: Deb Autor

Amneal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Deb Autor”): 250,782,208 for, 20,907,573 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2027 Annual Meeting of Stockholders and until their respective successo…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 58,931,881 for, 5,596,535 against, 16,038 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Election of Directors: Gautam Patel

Amneal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Gautam Patel”): 270,643,127 for, 1,042,157 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2027 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 64,486,289 for, 38,163 against, 20,002 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Election of Directors: J. Kevin Buchi

Amneal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: J. Kevin Buchi”): 247,071,067 for, 24,615,560 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2027 Annual Meeting of Stockholders and until their respective successo…”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 55,715,799 for, 8,808,653 against, 20,002 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Election of Directors: Jeff George

Amneal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Jeff George”): 250,652,568 for, 21,032,093 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2027 Annual Meeting of Stockholders and until their respective successo…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 58,889,756 for, 5,634,697 against, 20,002 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Election of Directors: John Kiely

Amneal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: John Kiely”): 239,969,127 for, 31,717,386 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2027 Annual Meeting of Stockholders and until their respective successo…”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 52,542,302 for, 11,982,149 against, 20,002 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Election of Directors: Paul Meister

Amneal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Paul Meister”): 237,733,309 for, 33,950,919 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2027 Annual Meeting of Stockholders and until their respective successo…”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 52,353,694 for, 12,170,759 against, 20,002 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Election of Directors: Shlomo Yanai

Amneal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Shlomo Yanai”): 250,631,212 for, 21,053,488 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2027 Annual Meeting of Stockholders and until their respective successo…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 58,889,756 for, 5,634,697 against, 20,002 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Election of Directors: Ted Nark

Amneal Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Ted Nark”): 265,399,266 for, 6,285,254 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2027 Annual Meeting of Stockholders and until their respective successo…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 61,312,330 for, 3,212,121 against, 20,002 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Advisory vote to approve executive compensation.

Amneal Pharmaceuticals, Inc.’s own tally for this item (“2. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers”): 269,089,785 for, 2,577,481 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 90 managers: 64,195,498 for, 334,632 against, 16,038 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 249 managers: 76,480,987 for, 1,180,034 against, 5,974 abstained. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026.

Amneal Pharmaceuticals, Inc.’s own tally for this item (“3. To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 293,211,820 for, 409,435 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 64,517,707 for, 14,822 against, 16,038 abstained.

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.